The pharmaceutical industry offers several protease inhibitors, which are used in the treatment of human diseases, such as dabigatran used in the treatment of pulmonary embolism and angiotensin converting enzyme inhibitors (ACEI) used in the treatment of hypertension92,105,106. This evidence concerns the gene ACE and pulmonary embolism.